203 related articles for article (PubMed ID: 28544579)
1. Frizzled7 Antibody-Functionalized Nanoshells Enable Multivalent Binding for Wnt Signaling Inhibition in Triple Negative Breast Cancer Cells.
Riley RS; Day ES
Small; 2017 Jul; 13(26):. PubMed ID: 28544579
[TBL] [Abstract][Full Text] [Related]
2. A novel recombinant human Frizzled-7 protein exhibits anti-tumor activity against triple negative breast cancer via abating Wnt/β-catenin pathway.
Xie W; Zhang Y; He Y; Zhang K; Wan G; Huang Y; Zhou Z; Huang G; Wang J
Int J Biochem Cell Biol; 2018 Oct; 103():45-55. PubMed ID: 30096373
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Wnt signaling by Frizzled7 antibody-coated nanoshells sensitizes triple-negative breast cancer cells to the autophagy regulator chloroquine.
Wang J; Dang MN; Day ES
Nano Res; 2020 Jun; 13(6):1693-1703. PubMed ID: 33304449
[TBL] [Abstract][Full Text] [Related]
4. A novel humanized Frizzled-7-targeting antibody enhances antitumor effects of Bevacizumab against triple-negative breast cancer via blocking Wnt/β-catenin signaling pathway.
Xie W; Zhao H; Wang F; Wang Y; He Y; Wang T; Zhang K; Yang H; Zhou Z; Shi H; Wang J; Huang G
J Exp Clin Cancer Res; 2021 Jan; 40(1):30. PubMed ID: 33436039
[TBL] [Abstract][Full Text] [Related]
5. Cell growth inhibition and apoptosis in breast cancer cells induced by anti-FZD7 scFvs: involvement of bioinformatics-based design of novel epitopes.
Zarei N; Fazeli M; Mohammadi M; Nejatollahi F
Breast Cancer Res Treat; 2018 Jun; 169(3):427-436. PubMed ID: 29411237
[TBL] [Abstract][Full Text] [Related]
6. Frizzled7 as an emerging target for cancer therapy.
King TD; Zhang W; Suto MJ; Li Y
Cell Signal; 2012 Apr; 24(4):846-51. PubMed ID: 22182510
[TBL] [Abstract][Full Text] [Related]
7. Frizzled7 Promotes Epithelial-to-mesenchymal Transition and Stemness Via Activating Canonical Wnt/β-catenin Pathway in Gastric Cancer.
Li G; Su Q; Liu H; Wang D; Zhang W; Lu Z; Chen Y; Huang X; Li W; Zhang C; He Y; Fu L; Bi J
Int J Biol Sci; 2018; 14(3):280-293. PubMed ID: 29559846
[TBL] [Abstract][Full Text] [Related]
8. FZD7-Targeted Nanoparticles to Enhance Doxorubicin Treatment of Triple-Negative Breast Cancer.
Hoover EC; Ruggiero OM; Swingler RN; Day ES
ACS Omega; 2024 Mar; 9(12):14323-14335. PubMed ID: 38559981
[TBL] [Abstract][Full Text] [Related]
9. FZD7 has a critical role in cell proliferation in triple negative breast cancer.
Yang L; Wu X; Wang Y; Zhang K; Wu J; Yuan YC; Deng X; Chen L; Kim CC; Lau S; Somlo G; Yen Y
Oncogene; 2011 Oct; 30(43):4437-46. PubMed ID: 21532620
[TBL] [Abstract][Full Text] [Related]
10. In Silico Identification of Potential Inhibitors of the Wnt Signaling Pathway in Human Breast Cancer.
Alves Pinto I; Freitas Da Silveira NJ
J Comput Biol; 2020 Jul; 27(7):999-1010. PubMed ID: 31647315
[TBL] [Abstract][Full Text] [Related]
11. The Wnt/β-catenin signaling pathway: a potential therapeutic target in the treatment of triple negative breast cancer.
King TD; Suto MJ; Li Y
J Cell Biochem; 2012 Jan; 113(1):13-8. PubMed ID: 21898546
[TBL] [Abstract][Full Text] [Related]
12. Developing and characterization of single chain variable fragment (scFv) antibody against frizzled 7 (Fzd7) receptor.
Nickho H; Younesi V; Aghebati-Maleki L; Motallebnezhad M; Majidi Zolbanin J; Movassagh Pour A; Yousefi M
Bioengineered; 2017 Sep; 8(5):501-510. PubMed ID: 27849134
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticle-Mediated Co-Delivery of Notch-1 Antibodies and ABT-737 as a Potent Treatment Strategy for Triple-Negative Breast Cancer.
Valcourt DM; Dang MN; Scully MA; Day ES
ACS Nano; 2020 Mar; 14(3):3378-3388. PubMed ID: 32083466
[TBL] [Abstract][Full Text] [Related]
14. Preferential Inhibition of Wnt/β-Catenin Signaling by Novel Benzimidazole Compounds in Triple-Negative Breast Cancer.
Gangrade A; Pathak V; Augelli-Szafran CE; Wei HX; Oliver P; Suto M; Buchsbaum DJ
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29783777
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-504 functions as a tumor suppressor in hepatocellular carcinoma through inhibiting Frizzled-7-mediated-Wnt/β-catenin signaling.
Quan H; Li B; Yang J
Biomed Pharmacother; 2018 Nov; 107():754-762. PubMed ID: 30142536
[TBL] [Abstract][Full Text] [Related]
16. Wnt Signaling in Cancer: Not a Binary ON:OFF Switch.
Flanagan DJ; Vincan E; Phesse TJ
Cancer Res; 2019 Dec; 79(23):5901-5906. PubMed ID: 31431458
[TBL] [Abstract][Full Text] [Related]
17. RSPO2 suppresses colorectal cancer metastasis by counteracting the Wnt5a/Fzd7-driven noncanonical Wnt pathway.
Dong X; Liao W; Zhang L; Tu X; Hu J; Chen T; Dai X; Xiong Y; Liang W; Ding C; Liu R; Dai J; Wang O; Lu L; Lu X
Cancer Lett; 2017 Aug; 402():153-165. PubMed ID: 28600110
[TBL] [Abstract][Full Text] [Related]
18. Saikosaponin D from Radix Bupleuri suppresses triple-negative breast cancer cell growth by targeting β-catenin signaling.
Wang J; Qi H; Zhang X; Si W; Xu F; Hou T; Zhou H; Wang A; Li G; Liu Y; Fang Y; Piao HL; Liang X
Biomed Pharmacother; 2018 Dec; 108():724-733. PubMed ID: 30248540
[TBL] [Abstract][Full Text] [Related]
19. Niclosamide sensitizes triple-negative breast cancer cells to ionizing radiation in association with the inhibition of Wnt/β-catenin signaling.
Yin L; Gao Y; Zhang X; Wang J; Ding D; Zhang Y; Zhang J; Chen H
Oncotarget; 2016 Jul; 7(27):42126-42138. PubMed ID: 27363012
[TBL] [Abstract][Full Text] [Related]
20. Fzd7 (Frizzled-7) Expressed by Endothelial Cells Controls Blood Vessel Formation Through Wnt/β-Catenin Canonical Signaling.
Peghaire C; Bats ML; Sewduth R; Jeanningros S; Jaspard B; Couffinhal T; Duplàa C; Dufourcq P
Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2369-2380. PubMed ID: 27758766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
